Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
about
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisA review of anabolic therapies for osteoporosisEffect of simvastatin on bone markers in osteopenic women: a placebo-controlled, dose-ranging trial [ISRCTN85429598]Statins as modulators of bone formation.Mechanisms of bone anabolism regulated by statinsOngoing clinical trials of the pleiotropic effects of statinsHyperlipidemia impairs osteoanabolic effects of PTH.Osteoporosis piece of multi-morbidity puzzle in geriatric care.Statin use and hip fractures in U.S. kidney transplant recipients.Statins and osteoporosis: new role for old drugs.Potential use of HMG-CoA reductase inhibitors for osteoporosis.Effects of D-003 (10 mg/day) on bone mineral density of the lumbar spine and femoral neck in postmenopausal women: a randomized, double-blinded study.Recognition of morphometric vertebral fractures by artificial neural networks: analysis from GISMO Lombardia Database.Statins and osteoporosis: a clinical review.Statin therapy and risk of fracture: results from the JUPITER randomized clinical trial.Emerging and potential therapies for osteoporosis.Efficacy of statins for osteoporosis: a systematic review and meta-analysis.Novel applications of statins for bone regenerationStatins and hip fracture prevention--a population based cohort study in womenStatins and bone metabolism.Emerging pharmacologic therapies for osteoporosis.Effects of Statins on Bone Mineral Density and Fracture Risk: A PRISMA-compliant Systematic Review and Meta-AnalysisClinical review: Statins and trauma--a systematic review.The effect of simvastatin on the proliferation and differentiation of human bone marrow stromal cells.Use of medications and risk of revision after primary total hip arthroplasty.Should we abandon statins in the prevention of bone fractures?Clinical Factors, Disease Parameters, and Molecular Therapies Affecting Osseointegration of Orthopedic Implants.Statins are associated with a reduced risk of bone fracture in hemodialysis (HD) patients.Exposure to statins is associated to fracture risk reduction in elderly people with cardiovascular disease: evidence from the AIFA-I-GrADE observational project.Statin use does not protect from fractures: the healthy adherer effect is a plausible explanation in observational studies.Synergistic effect of statins and postmenopausal hormone therapy in the prevention of skeletal fractures in elderly women.Statins decrease bone turnover in postmenopausal women: a cross-sectional study.The vital osteoclast: how is it regulated?Determinants of the differences in LDL-cholesterol after initiation of statin treatment.High-potency statins but not all statins decrease the risk of new-onset osteoporotic fractures: a nationwide population-based longitudinal cohort study.Local injection of a single dose of simvastatin augments osteoporotic bone mass in ovariectomized rats.Long-term effect of statins on the risk of new-onset osteoporosis: A nationwide population-based cohort study.
P2860
Q24194514-C698254A-1379-456E-A636-3F693E98CB40Q24797842-4488D609-9E14-44F4-9BD7-F29DD76867C6Q24803192-B8E9AE20-301D-47B8-A3CD-F5B5018DD018Q24806116-3776B5F5-38CF-4731-8794-F66F4D5E72F8Q26992028-BC8F6147-ECAD-4438-BE7B-3E82688E09DFQ28219321-520663F0-D78F-446C-BA44-874612C1473DQ33337922-C9825697-00F7-47B9-9130-E42694894CD5Q33351754-1E2476E8-0A7C-410F-9564-7EFD7534150FQ33623526-7F46595A-1574-4C22-833E-0F948E64BA47Q34563901-A7497099-58D3-46E7-992B-0E80C66F25FDQ34579635-30EB13FB-71C5-4DED-90FF-756A77109016Q35033570-F12435CC-628A-445C-B659-88CB4925DEF5Q35528208-61A97D8B-33FB-4D54-A28C-A2873E9D3A93Q36070930-974D9274-EA39-4A56-A5CE-A6B2A70B57C7Q36082922-47E820BE-6047-4257-A9EF-5E44A43295A6Q36099415-20417AB5-C525-4AA1-B3ED-5A0716D797A5Q36204400-6CF623F7-5896-4F28-AFFC-E145A193BD0BQ36240108-FEE75F05-E203-40D0-9B05-6652E75D7BC7Q36353931-8F378B20-A14D-4C3A-A925-FF979F9C0367Q36395695-5D2916B3-69F7-4F85-845F-F787333AEF37Q36944034-1D1FA68F-DA62-4875-A6A0-391DC211549DQ36988655-07CA1219-2816-4664-918B-261D6348BF5BQ36998040-08CB0981-70D4-4E08-92B8-8A7E0F19B861Q37433910-7EC9B43B-B3E8-4920-B3E8-899CB51388A6Q37812617-B6C7A410-90E8-4E26-AADF-155BAD8334CAQ38092753-BFF0ED29-F671-48BB-915D-23CC18E2B331Q39051157-2BFB2D6B-199D-4E68-B590-65973198E402Q40105699-D9BB8EA9-19CA-4723-9355-AD5C22511DEFQ40260979-E607C550-2AB9-466A-AED7-96152112B174Q42344038-8F4BF956-CC01-458E-A6A9-B7702B5EC20CQ43755260-23AC073F-6D28-4F85-BE01-40AF908666DAQ44111068-D7413BD4-769C-45C8-9C81-E2184342ADD0Q44970710-9E371DC0-8537-46A7-A278-FD8D14A17FD2Q46827248-6F987EE0-002F-482F-BDFD-F1E818F64F6CQ49706546-95F3EE81-6842-4487-A271-894F55111856Q51791983-BB633BBA-6D79-42BD-A68E-FF8D210FE2D6Q55472823-BF76083B-82D7-44C4-B0C7-95C4CC2E450E
P2860
Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@ast
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@en
type
label
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@ast
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@en
prefLabel
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@ast
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@en
P2093
P1433
P1476
Effect of pravastatin on frequ ...... vastatin in Ischaemic Disease.
@en
P2093
S MacMahon
P304
P356
10.1016/S0140-6736(00)04042-3
P407
P577
2001-02-01T00:00:00Z